Literature DB >> 20630874

Probing the role of CXC motif in chemokine CXCL8 for high affinity binding and activation of CXCR1 and CXCR2 receptors.

Prem Raj B Joseph1, Jose M Sarmiento, Anurag K Mishra, Sandhya T Das, Roberto P Garofalo, Javier Navarro, Krishna Rajarathnam.   

Abstract

All chemokines share a common structural scaffold that mediate a remarkable variety of functions from immune surveillance to organogenesis. Chemokines are classified as CXC or CC on the basis of conserved cysteines, and the two subclasses bind distinct sets of GPCR class of receptors and also have markedly different quaternary structures, suggesting that the CXC/CC motif plays a prominent role in both structure and function. For both classes, receptor activation involves interactions between chemokine N-loop and receptor N-domain residues (Site-I), and between chemokine N-terminal and receptor extracellular/transmembrane residues (Site-II). We engineered a CC variant (labeled as CC-CXCL8) of the chemokine CXCL8 by deleting residue X (CXC → CC), and found its structure is essentially similar to WT. In stark contrast, CC-CXCL8 bound poorly to its cognate receptors CXCR1 and CXCR2 (K(i) > 1 μm). Further, CC-CXCL8 failed to mobilize Ca(2+) in CXCR2-expressing HL-60 cells or recruit neutrophils in a mouse lung model. However, most interestingly, CC-CXCL8 mobilizes Ca(2+) in neutrophils and in CXCR1-expressing HL-60 cells. Compared with the WT, CC-CXCL8 binds CXCR1 N-domain with only ∼5-fold lower affinity indicating that the weak binding to intact CXCR1 must be due to its weak binding at Site-II. Nevertheless, this level of binding is sufficient for receptor activation indicating that affinity and activity are separable functions. We propose that the CXC motif functions as a conformational switch that couples Site-I and Site-II interactions for both receptors, and that this coupling is critical for high affinity binding but differentially regulates activation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20630874      PMCID: PMC2937958          DOI: 10.1074/jbc.M110.146555

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Large-scale conformational dynamics of the HIV-1 integrase core domain and its catalytic loop mutants.

Authors:  Matthew C Lee; Jinxia Deng; James M Briggs; Yong Duan
Journal:  Biophys J       Date:  2005-02-24       Impact factor: 4.033

Review 2.  Structural basis of chemokine receptor function--a model for binding affinity and ligand selectivity.

Authors:  Lavanya Rajagopalan; Krishna Rajarathnam
Journal:  Biosci Rep       Date:  2006-10       Impact factor: 3.840

3.  Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration.

Authors:  J R White; J M Lee; P R Young; R P Hertzberg; A J Jurewicz; M A Chaikin; K Widdowson; J J Foley; L D Martin; D E Griswold; H M Sarau
Journal:  J Biol Chem       Date:  1998-04-24       Impact factor: 5.157

4.  Monomeric variants of IL-8: effects of side chain substitutions and solution conditions upon dimer formation.

Authors:  H B Lowman; W J Fairbrother; P H Slagle; R Kabakoff; J Liu; S Shire; C A Hébert
Journal:  Protein Sci       Date:  1997-03       Impact factor: 6.725

5.  Differential mechanisms of recognition and activation of interleukin-8 receptor subtypes.

Authors:  K Suetomi; Z Lu; T Heck; T G Wood; D J Prusak; K J Dunn; J Navarro
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

6.  Disulfide bridges in interleukin-8 probed using non-natural disulfide analogues: dissociation of roles in structure from function.

Authors:  K Rajarathnam; B D Sykes; B Dewald; M Baggiolini; I Clark-Lewis
Journal:  Biochemistry       Date:  1999-06-15       Impact factor: 3.162

7.  Probing receptor binding activity of interleukin-8 dimer using a disulfide trap.

Authors:  Krishna Rajarathnam; Gregory N Prado; Harshica Fernando; Ian Clark-Lewis; Javier Navarro
Journal:  Biochemistry       Date:  2006-06-27       Impact factor: 3.162

8.  Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1.

Authors:  M P Crump; J H Gong; P Loetscher; K Rajarathnam; A Amara; F Arenzana-Seisdedos; J L Virelizier; M Baggiolini; B D Sykes; I Clark-Lewis
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

9.  CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. Determinants of high affinity binding and receptor activation are distinct.

Authors:  S K Ahuja; J C Lee; P M Murphy
Journal:  J Biol Chem       Date:  1996-01-05       Impact factor: 5.157

10.  Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development.

Authors:  Y R Zou; A H Kottmann; M Kuroda; I Taniuchi; D R Littman
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

View more
  23 in total

1.  Solution NMR characterization of WT CXCL8 monomer and dimer binding to CXCR1 N-terminal domain.

Authors:  Prem Raj B Joseph; Krishna Rajarathnam
Journal:  Protein Sci       Date:  2014-11-28       Impact factor: 6.725

2.  Chemokine CXCL1 dimer is a potent agonist for the CXCR2 receptor.

Authors:  Aishwarya Ravindran; Kirti V Sawant; Jose Sarmiento; Javier Navarro; Krishna Rajarathnam
Journal:  J Biol Chem       Date:  2013-03-11       Impact factor: 5.157

3.  Structure of monomeric Interleukin-8 and its interactions with the N-terminal Binding Site-I of CXCR1 by solution NMR spectroscopy.

Authors:  Sabrina Berkamp; Sang Ho Park; Anna A De Angelis; Francesca M Marassi; Stanley J Opella
Journal:  J Biomol NMR       Date:  2017-11-15       Impact factor: 2.835

Review 4.  New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model.

Authors:  Andrew B Kleist; Anthony E Getschman; Joshua J Ziarek; Amanda M Nevins; Pierre-Arnaud Gauthier; Andy Chevigné; Martyna Szpakowska; Brian F Volkman
Journal:  Biochem Pharmacol       Date:  2016-04-19       Impact factor: 5.858

5.  The chemokine X-factor: Structure-function analysis of the CXC motif at CXCR4 and ACKR3.

Authors:  Michael J Wedemeyer; Sarah A Mahn; Anthony E Getschman; Kyler S Crawford; Francis C Peterson; Adriano Marchese; John D McCorvy; Brian F Volkman
Journal:  J Biol Chem       Date:  2020-08-11       Impact factor: 5.157

Review 6.  How do chemokines navigate neutrophils to the target site: Dissecting the structural mechanisms and signaling pathways.

Authors:  Krishna Rajarathnam; Michael Schnoor; Ricardo M Richardson; Sudarshan Rajagopal
Journal:  Cell Signal       Date:  2018-11-19       Impact factor: 4.315

7.  Novel Human Cytomegalovirus Viral Chemokines, vCXCL-1s, Display Functional Selectivity for Neutrophil Signaling and Function.

Authors:  Jinho Heo; Pranay Dogra; Tom J Masi; Elisabeth A Pitt; Petra de Kruijf; Martine J Smit; Tim E Sparer
Journal:  J Immunol       Date:  2015-05-18       Impact factor: 5.422

8.  Role of N-glycosylation sites and CXC motifs in trafficking of medicago truncatula Nod factor perception protein to plasma membrane.

Authors:  Benoit Lefebvre; Doerte Klaus-Heisen; Anna Pietraszewska-Bogiel; Christine Hervé; Sylvie Camut; Marie-Christine Auriac; Virginie Gasciolli; Alessandra Nurisso; Theodorus W J Gadella; Julie Cullimore
Journal:  J Biol Chem       Date:  2012-02-09       Impact factor: 5.157

9.  Dynamic conformational switching in the chemokine ligand is essential for G-protein-coupled receptor activation.

Authors:  Prem Raj B Joseph; Kirti V Sawant; Angela Isley; Mesias Pedroza; Roberto P Garofalo; Ricardo M Richardson; Krishna Rajarathnam
Journal:  Biochem J       Date:  2013-12-01       Impact factor: 3.857

Review 10.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.